AGP logo

AGP Limited AGP

Market closed

Rs 192.17

-1.47 (-0.76%)

Vol143,417Updated10:3029 Jul 2026

01At a Glance

The headline take on AGP — valuation, income, returns, and efficiency

Consolidated snapshot

AGP Limited (AGP), commonly searched as AGP Pharma, is a Pharmaceuticals company listed on the Pakistan Stock Exchange. As of 29 Jul 2026, AGP last traded at Rs 192.17 (-0.76% on the day) with a market cap of Rs 53.81B and a free float of 30.0%. Over the last 12 months the stock has returned +0.1%. Cash dividends declared over the trailing 12 months total Rs 8.00/share (yield 4.2%). The stock trades at a P/E of 14.4x. A member of the KSE-100 index.

Prices through 29 Jul 2026 · FY data through FY25 · Quarterly through Mar-26

14.4x
Rs 13.34
1Y Return
+0.1%
Rs 53.81B

02Price & Performance

Closing prices across timeframes, returns, and range context

AGP — Price History

Daily closing series · toggle period below

1M Return-6.9%
3M Return+1.2%
6M Return-14.2%
1Y Return+0.1%
Day's Range69% of range
Rs 192.17
LowRs 190.00
HighRs 193.15
52-Week Range30% of range
Rs 192.17
LowRs 163.00
HighRs 258.67

03Key Metrics

Valuation, profitability, structure, and risk in one grid

14.4xTrailing annual EPS
Rs 13.34Latest annual · basic
3.14xBook Rs 61.14
4.16%Rs 8.00/sh trailing 12m
1.00Lower than market
Rs 53.81BMid cap
30.0%84M shares
58.64Moderate leverage
23.6%Latest annual
Rs 10Per share

04Dividend History & Yield

Payout track record, yield trend, and upcoming distribution

AGP has paid Rs 8.00 per share in cash dividends over the trailing 12 months — a 4.2% yield at the last close. Its most recent payout was Rs 6.00/share, announced 24 Mar 2026 with book closure from 14 Apr 2026. Annual dividend-per-share history back to 2020 is charted below.

Latest Payout

Per Share
Rs 6.00
Trailing Yield
4.16%
Payout Ratio
Announced
24 Mar 2026

Dividend Per Share Trend

2021
Rs 2.50
2022
Rs 2.00
2023
Rs 2.50
2024
Rs 4.00
2025
Rs 8.00

Payout History

Source: PSX company payouts

AnnouncedFor PeriodTypeAmountBook Closure
24 Mar 202631 Dec 2025 (YR)CashRs 6.00(60%)14 Apr 2026 – 20 Apr 2026
27 Aug 202530 Jun 2025 (HYR)CashRs 2.00(20%)04 Sept 2025 – 05 Sept 2025
28 Feb 202531 Dec 2024 (YR)CashRs 4.00(40%)03 Apr 2025 – 10 Apr 2025

05Financials & Earnings

Income, balance sheet, and key ratios from published accounts

AGP's market capitalisation stands at Rs 53.81B as of 29 Jul 2026 down 1.4% over the past 12 months (from Rs 54.59B).

Financial Statements

How OGDC's income and balance sheet have evolved

PKR MillionsFY25FY24FY23FY22FY21FY20Trend
Net Sales / Revenue28,89025,03418,74314,4599,3176,946
Cost of Sales11,63510,4828,7037,1284,2623,086
Gross Profit17,25514,55110,0407,3315,0553,861
Administrative Expenses1,003942714563473227
Operating Profit8,3657,3064,4153,1232,6192,230
EBITDA8,8597,7104,7353,3742,7982,374
Other Income120136122905132
Financial Charges1,4432,6931,629535205152
Profit Before Tax6,6974,4472,6342,4402,3081,927
Taxation2,3621,486811736462339
Profit After Tax4,3352,9611,8231,7051,8461,587
EPS - Basic (Rs)Rs 13.34Rs 9.53Rs 5.59Rs 5.61Rs 6.24Rs 5.67

All figures in PKR millions from published accounts.

Profitability & Returns

Margins, returns on capital, and earnings per share

Latest · FY25

RatioValue
Net profit margin15.0%
Gross profit margin59.7%
EBITDA margin30.7%
EBIT margin29.0%

Net profit margin

Net profit ÷ revenue · %

0.0%5.7%11.4%17.1%22.8%22.8%FY2019.8%FY2111.8%FY229.7%FY2311.8%FY2415.0%FY25Period
Earlier periodsLatest period

Financial Health

Coverage, leverage, and the strength of the balance sheet

Latest · FY25

RatioValue
Effective tax rate35.3%

Effective tax rate

Taxation ÷ profit before tax · %

0.0%8.8%17.6%26.5%35.3%17.6%FY2020.0%FY2130.2%FY2230.8%FY2333.4%FY2435.3%FY25Period
Earlier periodsLatest period

Market cap trajectory

Close × current shares outstanding · current Rs 53.81B

Rs 68.12BRs 47.97BRs 27.82BRs 7.68BJul 25Sept 25Nov 25Jan 26Mar 26May 26Rs 53.81B

Valuation & Capital Returns

What the market is paying for AGP, and what it returns to shareholders

Latest · FY25

RatioValue
Price to earnings15.23x
Price to sales1.97x

Price to earnings

Period-end price ÷ EPS · times

0.00x5.02x10.04x15.06x20.08x20.08xFY2015.54xFY2111.58xFY2212.58xFY2317.85xFY2415.23xFY25Period
Earlier periodsLatest period

06Technical Analysis

Trading signal, moving averages, momentum, and key levels

Trading Signal
SELL

10-day SMA (Rs 193.75) is below the 30-day SMA (Rs 202.71). RSI at 41 sits in the neutral band.

As of29 Jul 2026

PeriodValuevs CurrentPosition
SMA 10Rs 193.75+0.82%Below
SMA 30Rs 202.71+5.49%Below
SMA 60Rs 193.86+0.88%Below
SMA 200Rs 197.40+2.72%Below
41Neutral
0 · Oversold305070100 · Overbought

At 41, momentum sits within the neutral band (30–70), suggesting balanced buying and selling pressure.

MACD
Bearish Cross
  • MACD-2.21
  • Signal-0.73
  • Histogram-1.48
R2Resistance 2
Rs 230.32
19.9%
R1Resistance 1
Rs 211.25
9.9%
NOWCurrent
Rs 192.17
S1Support 1
Rs 180.55
-6.0%
S2Support 2
Rs 168.92
-12.1%

07Leverage Insights

MTS, margin financing, futures open interest, and combined exposure

Rs 59.99M
Margin Trading System
Rs 95.88M
Margin financing
Rs 155.87M
-45.68% MoMMTS + MFS combined

Leverage Composition

MTS · MFS stacked over the selected window

As of 16 Jul 2026

No blank sales

No net blank (short) sales reported for AGP on the latest PSX DFC report.

08Settlement Insights

UIN-wise settlement concentration and price context

Metrics and charts over the selected trailing window

Latest UIN %83.56%Most recent print
Average · 3M70.78%Mean over window
Change · 3M+15.59%First → last
Range · 3M40.4–93.3%Low–high

Settlement % Trajectory

Solid = UIN settlement % · Dashed = 14-session EMA

As of 16 Jul 2026

Price vs Settlement

Close price (left axis) · UIN settlement % (right axis)

09Share Structure & Capital

Float composition, capital base, and enterprise value

Free float · 30.0%Non-float · 70.0%

Free float vs locked-in holdings

Paid-Up CapitalRs 2.80B
Total Shares280M
84M
30.0%
Year EndDec
Enterprise Value

10About the Company

Business description, governance, and corporate information

AGP Limited was incorporated as a public limited company in May 2014 under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company got listed on Pakistan Stock Exchange Limited on 05 March 2018. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of all kinds of pharmaceutical products. Aitkenstuart Pakistan (Private) Limited (parent company) holds 55.80% of the share capital of the Company and West End 16 Pte Limited, Singapore is the ultimate parent company.

KSE-100Shariah CompliantPharmaceuticals

Corporate Information

  • RegistrarCDC Share Registrar Services Limited
  • AuditorGrant Thornton Anjum Rehman Chartered Accountants
  • Websitewww.agp.com.pk
  • AddressB-23-C, S.I.T.E, Karachi
  • SectorPharmaceuticals
  • Financial Year EndDecember

Key People

NameRole
MKMuhammad Kamran Nasir
CEO
TMTariq Moinuddin Khan
Chairperson
MAMuhammad Asad Khan
Company Secretary

11Recent Announcements

Latest company filings as reported on PSX

12Peers in Pharmaceuticals

How the cohort is moving — same-sector stocks by market cap

AGP vs Pharmaceuticals sector median

Median across 14 sector constituents · nulls excluded per metric

MetricAGPSector median
14.4x16.0x
4.2%4.0%
23.6%22.3%
1-Year Return+0.1%-8.7%
Rs 53.81BRs 27.79B

13Frequently Asked Questions

The most common questions investors ask about AGP

Frequently Asked Questions

AGP closed at Rs 192.17 on 29 Jul 2026, down 0.76% on the day, within a 52-week range of Rs 163.00–258.67. Prices on this page refresh through the trading day; log in to BSL for live quotes.

Ready to invest in AGP?

Open a BSL trading account in under 10 minutes

Buy and sell AGP and 550+ other PSX-listed stocks with low commissions, real-time data, and a concierge research desk backing every trade.

Open Account